角膜移植

  • 网络cornea transplant;keratoplasty;penetrating keratoplasty;pkp
角膜移植角膜移植
  1. 我明白了,那个承诺给我做角膜移植的MichaelMalone又把我给晃点了

    I see that Michael " I 'm gonna get you a cornea transplant " Malone stiffed you again .

  2. 我在角膜移植的等候名单上。

    I 'm on this waiting list for a cornea transplant .

  3. 她接受了角膜移植的手术。

    She had undergone the corneal transplants .

  4. 采用DNA原位缺口末端标记检测角膜移植片中的凋亡细胞。

    TUNEL was used to detect the cell ′ s apoptosis in the corneal grafts .

  5. 穿透角膜移植术后房水前列腺素E2及蛋白质量浓度的动态变化

    Dynamic changes of prostaglandin E_ 2 and protein level in rabbit aqueous humor following penetrating keratoplasty

  6. Fas和Fas配体在角膜移植免疫排斥反应中的表达

    The expression of Fas and Fas ligand in penetrating keratoplasty rejection

  7. 目的了解核因子-κB(NF-κB)在大鼠同种异体角膜移植排斥反应中的表达,探讨其在角膜移植免疫排斥反应中的作用。

    Objective To investigate the expression of NF - κ B on the rat corneal graft , and evaluate its effect in penetrating keratoplasty rejection .

  8. ICAM-1与角膜移植排斥反应的研究进展

    Research improvement of ICAM-1 in keratoplasty rejection

  9. CsA滴眼液治疗穿透角膜移植术后排斥反应的随机、双盲、多中心临床研究

    The randomized , double blindness , multi-center clinical trail for CsA on rejection following PRK

  10. 猪小肠黏膜下层(SIS)作为板层角膜移植材料的实验研究

    Experimental Research of Porcine Small Intestinal Submucosa ( SIS ) to Become Material of Lamellar Keratoplasty

  11. 真菌性角膜炎治疗性角膜移植术后局部应用FK506的临床评价

    Clinical evaluation of topical FK506 in the management of therapeutic keratoplasty for fungal keratitis

  12. 环孢霉素A(CyclosporinA,CsA)对穿透性异种角膜移植的影响&免疫学检测与形态学观察

    The Effect of Cyclosporin A ( CsA ) on Penetrating Heterografts : Immunologic Study and Histopathologic Examination

  13. TGFβ2-DC对小鼠同种异体角膜移植排斥反应的抑制作用

    Suppression effects of TGF β 2-DC on corneal allograft rejection

  14. 缓释胶原膜载FK506抗兔角膜移植术后免疫排斥反应实验研究

    A Study of FK506 Delivery Collagen Membrane Suppression on Immunologic Rejection in Rabbit of Corneal Transplantation

  15. 结论:在高危角膜移植中,GC与SEB共同使用不能增加移植片存活时间;

    CONCLUSION : SEB plus glucocorticoid cannot increase the survival time of corneal graft in high risk corneal transplantation .

  16. 联合PTK的全厚植片深板层角膜移植术临床及实验研究

    Clinical and laboratory study of full-thickness lamellar keratoplasty combined with PTK

  17. HLA氨基酸残基配型在角膜移植中的应用研究四角切圆煤粉炉生物质气与煤粉混燃数值模拟

    Clinical Application of Human Leucocyte Antigen ( HLA ) Amino Acid Residue Matching in Keratoplasty ; Numerical Simulation of the Gasification Based Biomass Co-firing in Tangentially Fired Pulverized Coal Boiler

  18. CNV也是角膜移植失败的首要原因,可显著增加角膜移植片排斥反应的危险性。

    CNV can result in the failure of corneal transplantation and remarkably increase the opportunity of rejecting reaction of corneal transplantation .

  19. 观察各组角膜移植术后排斥反应指数(RI)、植片存活时间(MST)和植片的病理变化。

    The rejection index ( RI ), means survival time ( MST ) of corneal grafts , and histopathological changes in corneal grafts were recorded .

  20. HLA-DRB1基因配型与高危角膜移植排斥关系的回顾性研究

    Retrospective study on efficacy of HLA-DRB_1 genetic typing in high risk corneal transplantation

  21. 目的探讨环孢霉素A(CsA)联合地塞米松局部滴眼预防高危穿透角膜移植(PKP)免疫排斥反应的效果。

    Objective To evaluate the effect of topical cyclosporin A ( CsA ) in preventing rejection after high-risk penetrating allograft keratoplasty ( PKP ) .

  22. Molteno管植入术治疗角膜移植术后难治性青光眼

    Implantation of the Molteno Tube for Refractory Glaucoma Following Penetrating Keratoplasty

  23. 移植排斥是角膜移植术失败的主要原因,尤其是植床上有大量新生血管(corneaneovascularization,CNV)的高危角膜移植患者,移植后排斥反应发生早且严重,移植物常被破坏。

    Background : The corneal transplant rejection is the major reason of failure for corneal transplantation , especially of patients with cornea neovascularization who are named as high-risk penetrating keratoplasty .

  24. B7分子作为重要的协同刺激分子,在角膜移植免疫排斥反应的发生及其治疗中起着重要作用。

    And as main co-stimulatory molecules of T lymphocyte activation , B7 plays a very important role in the occurrence and treatment of corneal graft rejective reaction .

  25. 目的:探讨FK-506抑制高危角膜移植免疫排斥反应临床应用的可行性及有效性。

    Objective : To evaluate the clinical probability and efficacy of FK-506 on suppressing cornea transplantation rejection .

  26. 用药期间未发现该药有任何毒副作用。结论:局部应用FK-506可有效抑制高危角膜移植免疫排斥反应的发生。

    Conclusions : The topical application of FK-506 suppressed effectively the postoperative graft rejection of high-risk cornea transplantation .

  27. 为了观察抗CD25单克隆抗体(ART-18)对角膜移植排斥反应的抑制作用,应用SD大鼠对Lewis大鼠进行穿透性角膜移植,术后用抗CD25McAb治疗。

    In order to observe the suppressive effect of anti-CD 25 monoclonal antibodies ( ART-18 ) on corneal graft rejection , the model of SD rat to Lewis rat penetrating Keratoplasty was applied , and were treated with anti-CD 25 McAb after operation .

  28. 方法对穿透角膜移植患者术后定期行CMTF检查。

    Methods The patients undergone penetrating keratoplasty were examined using in vivo confocal microscope through focusing ( CMTF ) .

  29. 结论32P标记供体白细胞预处理受体免疫学指标未见显著改变,提示该方法是安全可靠的,为抗角膜移植免疫排斥反应提供了新的手段。

    Conclusion The immunological indexes were not significantly changed after pretreatment of receptor by 32P labeled white blood cell , suggesting that such treatment is safe for cornea transplantation .

  30. 应用0.5%环孢霉素A(CyclosporinA,CsA)滴眼治疗穿透性角膜移植术后发生免疫排斥患者16例(16只眼),治愈9只眼,好转6只眼,无效1只眼。

    16 eyes with corneal allograft rejection after penetrating keratoplasty were treated with 0.5 % cyclosporin A ( CsA ) eyedrops , 9 eyes were completely cured , 6 eyes markedly improved , and one eye ineffective .